Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June ...

Former Avanos Medical executive Michael Greiner has left the company. Greiner was CFO and chief transformation officer at the ...

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

The cuts to the FDA are just one piece of the budget proposal, which looks to slash the HHS’ discretionary spending by ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing ...

Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...